The estimated Net Worth of Mark C Throdahl is at least $10.1 Milión dollars as of 11 March 2024. Mr. Throdahl owns over 2,433 units of OrthoPediatrics corp stock worth over $4,301,138 and over the last 7 years he sold KIDS stock worth over $4,630,985. In addition, he makes $1,190,150 as Chief Executive Officer a Director at OrthoPediatrics corp.
Mark has made over 12 trades of the OrthoPediatrics corp stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 2,433 units of KIDS stock worth $67,126 on 11 March 2024.
The largest trade he's ever made was selling 27,549 units of OrthoPediatrics corp stock on 13 April 2018 worth over $493,678. On average, Mark trades about 5,277 units every 103 days since 2017. As of 11 March 2024 he still owns at least 137,857 units of OrthoPediatrics corp stock.
You can see the complete history of Mr. Throdahl stock trades at the bottom of the page.
Mark C. Throdahl has been appointed as Chief Executive Officer, Director of the Company effective 6/3/2020. Prior to joining our company, Mr. Throdahl served from 2008 to 2009 as a Group President of Zimmer Holdings, Inc., a worldwide leader in orthopedic implants. Mr. Throdahl previously served from 2001 to 2007 as the Chief Executive Officer and Director of Consort Medical plc in London, United Kingdom. During a 13 year career at Becton Dickinson & Co., he served as Senior Vice President of the Drug Delivery sector and President of Nippon Becton Dickinson in Tokyo. Mr. Throdahl began his career at Mallinckrodt, Inc. Mr. Throdahl is a graduate of Princeton University and earned an MBA from Harvard Business School.
As the Chief Executive Officer a Director of OrthoPediatrics corp, the total compensation of Mark Throdahl at OrthoPediatrics corp is $1,190,150. There are no executives at OrthoPediatrics corp getting paid more.
Mark Throdahl is 69, he's been the Chief Executive Officer a Director of OrthoPediatrics corp since 2020. There are 4 older and 15 younger executives at OrthoPediatrics corp. The oldest executive at OrthoPediatrics corp is Stephen Burns, 76, who is the Independent Director.
Mark's mailing address filed with the SEC is 2850 Frontier Dr, Warsaw, IN 46582, USA.
Over the last 17 years, insiders at OrthoPediatrics corp have traded over $17,595,944 worth of OrthoPediatrics corp stock and bought 44,994 units worth $1,275,983 . The most active insiders traders include David R Pelizzon, John V. Schaefer a Mark C Throdahl. On average, OrthoPediatrics corp executives and independent directors trade stock every 24 days with the average trade being worth of $158,746. The most recent stock trade was executed by Daniel J Gerritzen on 21 August 2024, trading 10,000 units of KIDS stock currently worth $293,000.
orthopediatrics is the worldwide leader in pediatric orthopedics. we are the first company whose total focus is helping children with orthopaedic conditions and injuries by providing the surgeons who care for them with anatomically appropriate implants. every day, we focus purely on advancing the field of pediatric orthopedics through the innovative development of state-of-the-art technologies, commitment to quality products, and industry-leading support and clinical education with our experienced team of experts. our offering is continuing to expand as we strive to develop all of the necessary implants and instruments that a pediatric orthopedic surgeon needs to treat his/her patients, including: long bone deformity correction & trauma, spine, and sports medicine. as we continue to grow, we are looking for talented professionals to join our cause! visit our website to learn more about current openings, or submit a resume to careers@orthopediatrics.com!
OrthoPediatrics corp executives and other stock owners filed with the SEC include: